Procter & Gamble Q2 Net Sales Rise 1% to $22.2B; EPS Falls 5%
Wells Fargo increased Procter & Gamble’s price target to $177 and maintained an Overweight rating, citing the strongest Staples start versus the S&P 500. In Q2 fiscal 2026 Procter & Gamble reported $22.2 billion in net sales, 1% growth, diluted EPS of $1.78 down 5%, and returned $4.8 billion to shareholders.
1. Wells Fargo Price Target Upgrade
Wells Fargo raised Procter & Gamble’s price target to $177 from $165, maintaining an Overweight rating and citing the best start for the Staples sector versus the S&P 500 in the firm’s history.
2. Q2 Fiscal 2026 Sales Performance
Procter & Gamble reported net sales of $22.2 billion for Q2 fiscal 2026, marking 1% growth over the prior year with organic sales flat after adjusting for currency, acquisitions, and divestitures.
3. Earnings Decline Driven by Restructuring
Diluted net earnings per share decreased 5% to $1.78 due primarily to incremental restructuring charges, while core EPS held steady at $1.88 compared to the prior year.
4. Shareholder Cash Returns
The company returned $4.8 billion to shareholders through $2.5 billion in dividends and $2.3 billion in share repurchases during the quarter.